PTHS vs VTR · rev $16.8M vs P/E 149, rev $1.73B
Pelthos Therapeutics Inc. (PTHS) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
Latest reported VTR revenue for 2026-06-30 was $1.73B. Net income was $72.2M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
PTHS currently screens at market cap $94.7M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the PTHS and VTR stock pages for the full models.
Not investment advice.